We’re excited to announce that Uniogen has been granted US Patent for a groundbreaking optical innovation designed to elevate the performance of lateral flow (LF) test strip readers (US Patent No. US12228743B2). At the heart of this invention is a novel optical component that creates a homogenized and freely… Read More
Pioneering research from Uniogen at ESCMID Global 2025: We are excited to announce our participation in ESCMID Global 2025 in Vienna, where our scientists will present their groundbreaking research in C. difficile and B. pertussis diagnostics. This event brings together leading experts in clinical microbiology and infectious diseases, and… Read More
This February, we join the global community in recognizing World Cancer Day, a time to unite and amplify our commitment to reducing the impact of cancer worldwide. For us, it’s a powerful reminder of what we can achieve when we come together for a common cause. Read More
Advancement in product development, accelerated market entry and exhibitions: In 2024, Uniogen experienced an exceptional year marked by significant progress and innovations in research and development in the areas of oncology and new system development. Our R&D teams pushed boundaries, resulting in groundbreaking solutions that can be expected to set… Read More
Wishing you a joyous holiday season and a prosperous New Year filled with success and new opportunities! To recharge and celebrate the season, our team will be taking a short break over the holidays. While we’ll still be here to assist you, we will have fewer people in the office… Read More
Lumito has developed a ground-breaking histopathological tissue analysis solution called SCIZYS. The detection of the tissue samples is partly based on UpconTM nanoparticle technology provided by Uniogen. The technology is based on upconverting nanoparticles enabling autofluorescence free measurement. Combined with traditional brightfield imaging, it produces images… Read More
In August the company was accepted into the AMPlify program (an accelerated market entry platform), which is organized in collaboration with Mayo Clinic (USA) and Business Finland. The program supports the commercialization projects of the company’s ovarian cancer test currently under development. Our… Read More
Kaisa Huhtinen, Uniogen´s Oncology Clinical Manager, has a deep understanding of ovarian cancer diagnostics as a PhD and an Associate Professor. Kaisa is participating in the European Society of Medical Oncology (ESMO)– congress held in Barcelona the 13th – 17… Read More
Uniogen’s commitment to environmental, social, and governance (ESG) principles has never been stronger, as demonstrated in our 2023 Sustainability report. We caught up with Maija Jortikka, our Sustainability Specialist, to discuss this year’s highlights and the impactful changes Uniogen is implementing. Embracing a robust Code of Conduct Maija begins… Read More
April was an exciting month for Uniogen, filled with significant participation at three major global congresses that align closely with our mission and expertise. We are thrilled to share key insights and developments from these events, reinforcing our commitment to innovation and collaboration in the fields of clinical diagnostics… Read More
